[[100 µg, ABP-PAB-10302]]
(100 µg) PRDM2 may be a candidate target of 1p36 alterations that commonly occur in neuroendocrine, breast, liver, colon, skin, and lymphoid tumors.
Product Description Download/Print: 
0
